The tight correspondence between clinical benefit and macrophage polarity reported in osteoarthritis—ARG1/iNOS increases tracking pain relief and gait restoration—offers a biologically coherent template for interpreting the present multidomain improvements and motivated the same serum PD panel (ARG1/iNOS, IL-10, TNF-α) in our protocol [15]. This evidence concerns the gene TNF and osteoarthritis.